Artemis have reduced their holding from roughly 10% of shares in issue to around 5%, about 25 million shares.
As there has been no halt to the rise in the SP I am guessing it could be an exchange with another institution?
The 5% Artemis retain must be pretty much free carry shares?
Incredible investment this is turning out to be, one of my best ever.
"I am following up my recent article on how shares held in ISAs can be used as part of an inheritance tax (IHT) relief portfolio by suggesting some shares that could fit the bill.These are profitable and cash generative businesses with good track ..."
Good enough for me to get back aboard, I never felt comfortable being out, but profits must be taken sometimes.
There is a miracle cure for MACD on the horizon that may have an impact if it comes off I suppose.
But, if we can get Diclectin approved for sale in the UK that would more than make up for it.
Good Results. As I have said before APH is not a race-horse
but a reliable cart-horse. Steady as she goes, direction north
all the time. I reckon we shall see 75p a share before too
very long. A nice long-term hold.
You might be right, you might be wrong. Markets are certainly
overvalued, a retrace is due, when it comes it may indeed be a
sharp one, but then again it may not amount to much.
The problem with selling up is to subsequently decide when to
go back in. APH should be a resilient one but, as you say, even
the good ones can take a tumble in a market downturn.
We have seen a very strong rise to 70p at APH, this may result in
profit taking without there being a market downturn. I expect
a small retrace happening to perhaps 65p, but then again the
overall interest in APH is unlikely to diminish, therefore a
subsequent leg up (after the retrace) to region 80p region may
still be on the cards for this year.
Over the last week or so I get the feeling that markets are looking to retrace.
Good companies look overvalued and poor companies are starting to look overvalued too.
I sold my entire portfolio on Tuesday, winners and losers, at an overall profit.
Alliance was one of the biggest winners and it was with a slightly heavy heart that I hit the sell button. If any of my holdings could weather a retrace I would put my money on Alliance. However, I suspect it will be a sharp retrace that will hit everything regardless of quality. When panic sets in anything can happen.
What do you think, have I got off the bus too soon?
Share price now above 70p, I am pleased but not surprised
to see that. APH is the largest holding in my portfolio. I feel
safe with APH, as the demand for medicines (niche or
otherwise) is unlikely to diminish.
P.S. Off-topic / might I suggest a look at LPA, good figures there
this morning. But as always DYOR.
Actually invested in this and Tyratech and think this is a good move for both. Vamousse is a strong differentiated product in this segment, with USPs that will appeal to parents and a good presence already in UK grocers and in the big chains in the US. Good foundation for Alliance to build on.
Seems a reasonable acquisition, hopefully our reach can boost sales.
Have to admit I had never heard of Vamousse, but having never having head lice (as far as I know) why would I?
Still under the radar
APH is now the largest holding in my portfolio. In the frothy bull market we
are in, I feel comfortable with this not-overrated, calmly behaved steady
I have also a decent stake in INSE where for me much the same applies
(undervalued IMO) plus I can see a decent rise in the offing there,
imminent I would say. But as always DYOR.
Agree entirely ws,
Has everything I look for in a company, have to admit I followed them after seeing the naked trader was buying in post eu referendum.
It's one of those that seemed too good to be true, I looked and looked and looked but couldn't see any chinks in the armour. The only ? was the slightly high debt following the Sinclair acquisition, that is now under control.
Very happy with my purchase and think this has years of growth yet. Only regret is I didn't buy more when we were sub 50p!
H1 Results show steady sales progress and excellent cash flow.
I do like APH's no-nonsense accounts, no sneaky hidden things, all
facts honest & plain for all to see.
I hold APH long term (dividends beat bank interest, and there is
near constant sensible growth.
Share Crazy - Have a look at OPG Power (OPG), should I prove to
be correct in my views/comments there, then a substantial can't be too
far away there. But as always take care and DYOR.]
As for APH, I reckon we'll see 55p+ there in the not too distant future,
not a race horse, just a quiet docile work horse.
In the stocks & sh\ares investment world, no one sails along without mistakes.
I consider it a mistake to be selling APH. When the market takes a tumble
(which could happen any day) then established healthcare stocks like APH
are likely to suffer least. In my view, APH is a steady ship to sail on.
Games - The diclectiin issue is disappointing but by no means
disastrous. The share price need not go down as much as it has,
I reckon that we'll see a bottom at around 49p and then a
gradual rise again to region 52+. After all, the company's profits
are rising nicely without diclectin and the Dividend is good and
also rising nicely.
In recent days two big sellers have sold. Today's news it seems wasn't too detrimental according to the company. There wasn't volume to the sell off. If it moves below the 100 day moving average I will consider a short to hedge my long. What do you think?
Winning -- I'll take a look and it certainly seems to have some good history, however, I'm not usually a big fan of consulting companies as they tend to be expensive people wise, high operationally, especially when business turns south.
The only investment made since dropping AZN-GSK and Rathbones is OPG Power Ventures -- not a huge position and it's a strange choice for me, it being coal oreintated (moving into solar) but the fundamentals look good and it's incredibly undervalued if not a tad heavy ion debt.
It's highlighted by the Slater Growth Fund. -- see OPG board.
Games - After your sales of AZN and GSK you will have cash-funds to invest,
have a look at INSE for great growth potential as well a good dividends, as
well as, in my view, being jolly sound and quite safe.
well it looks a little safer than Astra and GSK this morning -- I'm glad to be out of both with a good profit and hopefully away from a substantial big downside if AZN's new drug doesn't work -- it's ominous that Sorryhat is leaving, if true, at a time when it should be imminent glory.
Perhaps he sees it failing and he'll then look like a chump for turning down the Pfizer deal.
Selling GSK for me was more to do with the declining ROCE over 5 years and the fact that the full effect of the recent off patent big drugs have still to take effect whilst new stuff is going to find it hard to be sufficient in terms of replacement business.
Important message from the Financial Conduct Authority:
Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse.
This could lead to an unlimited fine and up to seven years in prison.
If you have any information, concerns or queries about market abuse, click here.
The content of the messages posted represents the opinions of the author, and does not represent the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited.
You should be aware that the other participants of the above discussion group are strangers to you and may make statements which may be misleading, deceptive or wrong.
Please remember that the value of investments or income from them may go down as well as up and that the past performance of an investment is not a guide to its performance in the future.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements.
Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in.
Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.